MON-265 Once-Weekly Somapacitan in Japanese Adults with GH Deficiency Was Well Tolerated, with Similar Efficacy to Daily GH: A Randomized Trial

Somapacitan is a long-acting, reversible albumin-binding human growth hormone (GH) derivative based on a proven protraction technology. The objective of this trial was to evaluate the safety, efficacy and treatment satisfaction of once-weekly somapacitan compared with daily GH (Norditropin®) over 52...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Fumio, Takahashi, Yutaka, Tahara, Shigeyuki, Rasmussen, Michael Højby, Ogawa, Yoshihisa, Takano, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209108/
http://dx.doi.org/10.1210/jendso/bvaa046.605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209108/
http://dx.doi.org/10.1210/jendso/bvaa046.605

Ejemplares similares